Phase I/IIa trial of androgen deprivation therapy, external beam radiotherapy, and stereotactic body radiotherapy boost for high-risk prostate cancer (ADEBAR).
Yeon Joo KimHanjong AhnChoung-Soo KimYoung Seok KimPublished in: Radiation oncology (London, England) (2020)
ClinicalTrials.gov, ID; NCT03322020 - Retrospectively registered on 26 October 2017.